Key result
High lifetime CV risk linked to greater subclinical atherosclerosis burden and progression in younger adults.
Why the study?
Individuals with low 10-year but high lifetime cardiovascular risk may have greater subclinical atherosclerosis and progression, but this relationship in younger adults was unclear.
Do younger adults with low 10-year but high lifetime cardiovascular risk have greater subclinical atherosclerosis progression compared to those with low 10-year and low lifetime risk?
Do younger adults with low 10-year but high lifetime cardiovascular risk have greater subclinical atherosclerosis progression compared to those with low 10-year and low lifetime risk?
Younger adults with low short-term but high lifetime cardiovascular risk exhibit greater subclinical atherosclerosis and progression, highlighting the importance of lifetime risk assessment.
Supports lifetime risk assessment in younger adults; extends subclinical atherosclerosis data but remains hypothesis-generating.
Individuals with low 10-year but high lifetime risk have a greater subclinical disease burden and greater incidence of atherosclerotic progression compared with individuals with low 10-year and low lifetime risk, even at younger ages.
No takes yet. Share an insight, caveat, or question.
Berry et al. (2009) studied this question. Younger adults with low 10-year but high lifetime cardiovascular risk have greater subclinical atherosclerosis burden and progression compared to those with low lifetime risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: